The marked increase in the incidence of cancer and autoimmune diseases and the dramatic decrease in humoral and, to some extent, cellmediated immune capacity in aged mice are convincingly established (13, 17, 21) . Based on these and other data, Walford (21, 22) and Burnett (4) have introduced an immunological theory of aging-an extension of the somaticmutation theory of aging-wherein they suggest that, with advancing age, there is a gradual accumulation of mutated cells among the immunocompetent or other somatic cells of the body, or both, that can lead to immunological diseases. According to the theory, mature adults remain healthy and are free of these self-destructive autoimmune diseases because, presumably, immunological surveillance by a normally functioning, highly efficient immune system continually protects against infectious agents and aberrant (cancer) cells (5, 20, 21) . If For immunologic rejuvenation to be effective, the infused immunocompetent cells must (i) persist for an extended period without loss of functional capacity, (ii) perform maximally, and (iii) not produce histoincompatibility reactions against the host. If possible, the prospective recipient should not be subjected beforehand to physical or chemical insult. Based on these criteria and with the following questions in mind, a model test system has been developed in mice. (i) Can immunocompetent cells persist for an extended period of time in both young and aged syngeneic recipients and yield significant protection to an unirradiated host? (ii) Are immunocompetent cells from immunized donors superior to those from normal (nonimmunized) donors? (iii) Can immunocompetent cells be stored at liquid nitrogen temperature (-196 C) and thawed without appreciable loss of activity? The last question is unnecessary when using inbred laboratory animals, but is pertinent when studying species where inbred animals are not available. Thus, when using noninbred animals, a realistic approach is storage of the animal's own immunocompetent cells with subsequent retrieval and infusion to meet needs with advancing age.
To answer these questions, we have assessed the ability of infused spleen cells from youngadult mice immunized against a virulent strain of Salmonella typhimurium to protect both young and old mice from a parenterally induced infection with the same organism. This typlhimurium vaccine. The latter treatment resulted in markedly enlarged spleens, and only spleens weighing between 300 and 600 mg were used. Spleen cells were counted in a hemocytometer and adjusted to desired concentrations. Heparin (final concentration of 5 units/ml) was routinely added just prior to intravenous injection of 5 X 107 spleen cells into nonirradiated mice. However, an essential feature of the experimental design in "cell banking" experiments was injection of spleen cells into sublethally irradiated (600 R) mice.
Irradiation. Mice received a single whole-body exposure from a G.E. Maxitron X-ray machine. Irradiation conditions were 300 kvp, 20 ma; 175 R /min at a target-object distance of 70 cm; half-value layer, 0.4 mm of Cu; inherent filtration, 4.75 mm of Be; added filtration, 3 mm of Al.
Freezing, storage, and thawing of immunocompetent cells. A 20%7c suspension of dimethylsulfoxide in HBSS was slowly added, with continuous mixing, to an equal volume of a pooled spleen-cell suspension containing 4 X 108 cells/ml. Samples of 1-ml were transferred to glass ampoules which were sealed with a flame and then chilled in ice. The temperature was decreased at a rate of 1 C/min from 4 to -50 C, and the ampoules were stored at -196 C in liquid nitrogen. Two weeks later, cell suspensions were removed from the liquid nitrogen and quickly thawed by placing the ampoules in a 37 C water bath. Cells were diluted fourfold with HBSS prior to intravenous injection into recipient mice. RESULTS Three replicate experiments were carried out over a 6-month period. In each experiment, three groups of 10 to 15 mice each received decreasing numbers of S. typhimurium organisms per group. Minimal variation was found among the three experiments, so the data were pooled and mean lethal dose (LD5o) of 1.3 x 105 organisms was estimated by the method of Berkson (3) for young-adult (12-week-old) BC3F, mice following intraperitoneal injection (Table 1) . It should be emphasized that small increases in the number of challenge organisms introduced intraperitoneally produced marked increases in mortality, and it was a routine observation that challenge of mice with three LD50 resulted in 100%C mortality. VOL. 6, 1972 The protective capacity of spleen cells stored in liquid nitrogen. Albright et al. (2) have previously demonstrated that the antibody-synthesizing capacity of spleen cells to sheep erythrocytes is in no way impaired by freezing and prolonged storage. However, it was of paramount importance to demonstrate that this could be done in the present experimental system where both adoptively transferred cellular and humoral immunity could contribute to survival of challenged recipient mice. Accordingly, for this experiment, prospective recipient mice were X-irradiated (600 R) to destroy their ability to generate an immune response (12) . These animals were then injected with 5 x 107 fresh or stored spleen cells from immunized or normal (nonimmunized) donors and 1 day later were challenged with appropriate doses of S. typhimurium organisms. A preliminary investigation with fresh spleen cells injected into X-rayed recipients had established an appropriate challenge-inoculum dose range.
It can be seen from Fig. 1 that comparable 14-day mortalities were obtained in animals given stored (-196 C) or fresh spleen cells. That the protective capacity of stored spleen cells, from either previously immunized (Fig. 1A) or normal ( Fig. IB) mice, was as effective as that of fresh cells is further emphasized by the strikingly similar cumulative mortality curves seen when recipient mice were challenged with the same number of S. typhimurium organisms.
The enhanced protective capacity of spleen cells from immunized donors was dramatic when Fig. 2 presents the cumulative mortality of 36 133-to 140-week-old mice challenged with a 0.05-or 0.1 LD50 of organisms. Although almost half of these animals had been challenged with only a 0.05 LD50 dose of organisms, 100% mortality was reached by day 13. Abrupt, early mortality (1 day) accounted for over half of the deaths among the mice of this age group that had been challenged with a 0.1 LD50 of organisms.
After we established the general susceptibility of young-adult and aged mice, it was necessary to determine if sufficient numbers of adoptively transferred spleen cells from immunized donors would "take" in nonirradiated young-adult and aged recipient mice to confer significant protection against S. typhimurium infection. The data presented in Fig. 3 show that 2 to 4 weeks after receipt of 5 x 107 primed spleen cells, 95% of young-adult mice survived a challenge 100 times the LD50 (Fig. 3B) . The protective effect of primed spleen cells in aged (133 to 140 weeks) recipients was also impressive (Fig. 3A) . Although 100%o of aged mice succumbed to an inoculum of 0.05 or 0.1 LD50, a 10-to 20-fold greater challenge dose (1 LD50 for young-adult mice) 2 to 4 weeks after adoptive transfer of 5 X 107 primed spleen cells resulted in only 50% mortality. Duration of adoptive immunity. To determine if the transferred cells survived and retained their ability to provide long-lasting immunity in nonirradiated recipients, young-adult mice were challenged at various times after receipt of primed spleen cells. It can be seen in Fig. 4 that even after 40 weeks the transferred cells still provided a highly significant degree of protection. At this time these mice were highly susceptible to a 100 LD50 challenge dose of organisms, indicating a decline in the level of immunity. How- VOL. 6, 1972 Fig . 5 show that adoptive immunity radiated recipient mice is comparable X-irradiated recipient mice. This der that X-irradiation of the prospective r not an essential requirement for lIc "take" of transferred primed spleen ce pected, X-irradiated recipient mice v susceptible to challenge shortly after I weeks) for recovery of X-ray-suppre defense mechanisms was apparently in( DISCUSSION Survival and functional capacity is a requirement of immunological rej when transferred cells are used. Routin past, prospective recipients have been e X-rays or treated with immunosuppres prior to infusion of donor cells. The l rationale for such treatment is that X-i increases the amount of space available ferred cells, and it is tacitly assumed t X-irradiated recipient, transferred cell to compete on equal terms with u resident cells of the host because incre, bers of proliferative sites are availab regard Najarian and Jolicouer (16), isotopically labeled spleen cells froi munized donors, demonstrated that t lymphoid space available for transfc geneic cells doubled after X-irradiati cipient mice. Moreover, Celada (6) f the secondary antibody-forming ca previously immunized spleen cells is times better in X-irradiated than in nor syngeneic recipients when challenged ately after cell transfer.
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